Compare UCAR & PPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | UCAR | PPCB |
|---|---|---|
| Founded | 2013 | 2007 |
| Country | China | Australia |
| Employees | N/A | 2 |
| Industry | Retail-Auto Dealers and Gas Stations | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4M | 1.6M |
| IPO Year | 2022 | N/A |
| Metric | UCAR | PPCB |
|---|---|---|
| Price | $0.57 | $0.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $50.00 | N/A |
| AVG Volume (30 Days) | ★ 25.1M | 1.2M |
| Earning Date | 05-14-2026 | 05-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.04 | $0.10 |
| 52 Week High | $4.98 | $10.69 |
| Indicator | UCAR | PPCB |
|---|---|---|
| Relative Strength Index (RSI) | 51.54 | 34.79 |
| Support Level | N/A | N/A |
| Resistance Level | $1.71 | $0.40 |
| Average True Range (ATR) | 0.15 | 0.01 |
| MACD | 0.06 | 0.01 |
| Stochastic Oscillator | 35.16 | 41.34 |
U Power Ltd is involved in the provision of vehicle sourcing services. It is principally engaged in the provision of new energy vehicles development and sales; battery swapping stations manufacturing and sales; battery swapping services, and sourcing services. The company, as a broker, engaged in sales of vehicles between automobile wholesalers and buyers, including small and medium-sized vehicle dealers and individual customers located in lower-tier cities in China.
Propanc Biopharma Inc is a development-stage healthcare company. It focuses on developing new cancer treatments for patients suffering from pancreatic, ovarian, and colorectal cancer. The company develops a rational, composite formulation of the anti-cancer compound, which together exert a number of effects designed to control or prevent tumors from recurring and spreading through the body. Its product, PRP, is a variation upon its novel formulation and involves proenzymes, the inactive precursors of enzymes.